A variety of groups have focused their research on the association of I148M polymorphism with HCC susceptibility, failing to provide convincing evidence for the ADPN-HCC association most likely because of sample insufficiency of their published studies. This evidence concerns the gene PNPLA3 and hepatocellular carcinoma.